According to the new industry announcement, the company recently received a Class III “Medical Device Registration Certificate” issued by the State Drug Administration. The product is a herpes simplex virus type 2 nucleic acid detection kit. The registration certificate is valid from September 24, 2026 to September 23, 2031, and is used to qualitatively test HSV-2 DNA in male urethral swabs and female cervical swab samples in vitro. Up to now, the company has obtained 2 domestic medical device registration certificates for nucleic acid detection reagents. This certification has enriched the product categories related to nucleic acid testing, which has had a positive impact on the company's development, but it will not have a significant impact on recent production, operation and performance.

According to the new industry announcement, the company recently received a Class III “Medical Device Registration Certificate” issued by the State Drug Administration. The product is a herpes simplex virus type 2 nucleic acid detection kit. The registration certificate is valid from September 24, 2026 to September 23, 2031, and is used to qualitatively test HSV-2 DNA in male urethral swabs and female cervical swab samples in vitro. Up to now, the company has obtained 2 domestic medical device registration certificates for nucleic acid detection reagents. This certification has enriched the product categories related to nucleic acid testing, which has had a positive impact on the company's development, but it will not have a significant impact on recent production, operation and performance.